ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,722.26
-0.19%
US Tech 100
19,518.00
0.53%
Dow Jones
41,914.75
-0.70%
Brent Oil
71.98
-1.65%
Bitcoin
63,579.34
0.71%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Exagen Inc (XGN) Quote

Exagen Inc

Exagen Inc (XGN)

NASDAQ
2.98
-0.06
(-1.97%)
Closed September 26 4:00PM
Delayed by 15 minutes
2.84
-0.14
(-4.70%)
After Hours: 7:59PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
2.98
Bid
2.86
Ask
3.11
Volume
20,731
2.90 Day's Range 3.12
1.3003 52 Week Range 3.71
Market Cap
51.811M
Previous Close
3.04
Open
3.05
Last Trade
500
@
2.84
(formt)
Last Trade Time
Financial Volume
$ 63,293
VWAP
3.0531
Average Volume (3m)
58,434
Shares Outstanding
17,386,389
Dividend Yield
-
PE Ratio
-2.13
Earnings Per Share (EPS)
-1.36
Revenue
52.55M
Net Profit
-23.69M

About Exagen Inc

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differentia... Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.exagen.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Exagen Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker XGN. The last closing price for Exagen was $3.04. Over the last year, Exagen shares have traded in a share price range of $ 1.3003 to $ 3.71.

Exagen currently has 17,386,389 shares outstanding. The market capitalization of Exagen is $52.85 million. Exagen has a price to earnings ratio (PE ratio) of -2.13.

Ask ADVFN Intelligence (AI)

XGN Latest News

More News

Form 3 - Initial statement of beneficial ownership of securities

September 04 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

September 04 2024
Edgar (US Regulatory)

Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference

CARLSBAD, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2024 Cantor Global...

September 04 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

August 09 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 05 2024
Edgar (US Regulatory)

Form 8-K - Current report

August 05 2024
Edgar (US Regulatory)

Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance

CARLSBAD, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30...

August 05 2024
GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]

August 02 2024
Edgar (US Regulatory)

Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference

CARLSBAD, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 44th...

August 02 2024
GlobeNewswire Inc.

Form 8-K - Current report

August 02 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.093.114186851212.893.142.75288022.94639231CS
40.020.6756756756762.963.52132.71405763.02101611CS
121.2269.31818181821.763.711.71584342.80017877CS
261.3481.70731707321.643.711.3003468312.34246497CS
520.6930.13100436682.293.711.3003452972.10860672CS
156-10.66-78.152492668613.6414.851.3003407224.13532089CS
260-13.88-82.32502965616.8629.8581.3003462279.96689396CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RZLVRezolve AI Ltd
$ 7.44
(51.22%)
3.17M
RNAZTransCode Therapeutics Inc
$ 0.63
(51.12%)
12.73M
ATGLAlpha Technology Group Limited
$ 2.16
(49.72%)
3.42M
INVZWInnoviz Technologies Ltd
$ 0.18
(45.69%)
11.02k
OCTOEightco Holdings Inc
$ 3.61
(44.98%)
100.6M
VTNRVertex Energy Inc
$ 0.1501
(-58.42%)
49.72M
CMCTCreative Media and Community Trust Corporation
$ 0.71
(-54.63%)
3.56M
SFIXStitch Fix Inc
$ 2.28
(-39.20%)
23.88M
SHOTWSafety Shot Inc
$ 0.22
(-31.25%)
11.82k
ARQQArqit Quantum Inc
$ 4.40
(-29.63%)
438.63k
NVDANVIDIA Corporation
$ 123.51
(2.18%)
284.49M
MLGOMicroAlgo Inc
$ 0.2744
(26.92%)
142.29M
SQQQProShares UltraPro Short QQQ
$ 7.47
(-2.35%)
124.15M
CEROCERo Therapeutics Holdings Inc
$ 0.0986
(5.23%)
123.59M
INTCIntel Corporation
$ 23.54
(3.20%)
117.01M

Discussion

View Full Feed
Papa Grizz Papa Grizz 3 minutes ago
POP GOES THE WEASLE- Hold on tight gang. He He He
SHIBUSD
TradeSmart.ai TradeSmart.ai 3 minutes ago
Agreed this could be the big one when it starts flying $SINC
SINC
Juststoppingby Juststoppingby 3 minutes ago
We have been more focused on the silicon anode part of the battery.
In the last e-mail, they stated, “In fact, the Core Optics management team is currently hosting discussions with leading Korean cathode and battery developers, showing the diversity of and interest in advancing Endurion.”
CRTG
TradeSmart.ai TradeSmart.ai 4 minutes ago
Yuppo!!! Excellent close today boys very nice $SINC
SINC
TradeSmart.ai TradeSmart.ai 4 minutes ago
Wow very nice DD $LUDG
LUDG
TradeSmart.ai TradeSmart.ai 5 minutes ago
Sheeshhh nice close today, let’s see if we can double the volume tomorrow :-) $LUDG
LUDG
BeachBum BeachBum 11 minutes ago
Fungi and Rabbit game, really? Xavier isn’t a novice. Go to IMDb.
PSRU
cryptopunks cryptopunks 11 minutes ago
Yes, Lakota, it looks like an R/S is going to happen here. Worth a closer look.
IONI
Zorax Zorax 12 minutes ago
I've seen more people at a farm/estate auction.
fuagf fuagf 13 minutes ago
Mayor Eric Adams Indicted: Live Updates The still-sealed indictment reportedly includes allegations the mayor took foreign money.

By Intelligencer Staff

https://pyxis.nymag.com/v1/imgs/171/846/f64bfc54f6d36af3eadd2af8a3835d913a-eric-adams-court.rhorizontal.w1100.jpg
powerbattles powerbattles 14 minutes ago
The Kingdom of Saudi Arabia is developing a Green Pig Iron-making facility using HIsmelt technology. This project is a collaboration between Midmetal and Magnum, aiming to leverage high-grade magnetite concentrate from Magnum’s Buena Vista Iron Project in Nevada, USA, and mill waste from steel plant
VCIG
boston127 boston127 14 minutes ago
I saw this. i'm almost ready to jump

back in. The CEO lied to us all once. Not sure I can trust him.
ASII
BeachBum BeachBum 14 minutes ago
He never responds to basher trolls on Twitter which is strange, dontcha think? I’m guessing Xavier has something coming to drive the pps. Buy .0002 and .0003 on the move.
PSRU
powerbattles powerbattles 15 minutes ago
The Kingdom of Saudi Arabia is developing a Green Pig Iron-making facility using HIsmelt technology. This project is a collaboration between Midmetal and Magnum, aiming to leverage high-grade magnetite concentrate from Magnum’s Buena Vista Iron Project in Nevada, USA, and mill waste from steel plant
VCIG
boston127 boston127 15 minutes ago
You need a former cheerleader like me

to help you.I'm great, getting sweaty, in the grass. As far as my misunderstanding about the RS, take a chill pill everyone. I thought that it was still an issue.
IGPK
kund kund 16 minutes ago
As per Misleading’s calendar year 2030 is also near term.
AVXL
cryptopunks cryptopunks 16 minutes ago
Does this stock trade? It doesn't seem to be doing anything.
CFSU
boston127 boston127 19 minutes ago
How can you make such a vile

comment about your good friend? Of course, it does make me more interested in meeting you.
IGPK
powerbattles powerbattles 20 minutes ago
Enjoy bro.
janice shell janice shell 21 minutes ago
https://x.com/theliamnissan/status/1838768625479545190
1hot toddy 1hot toddy 21 minutes ago
EARNINGS $$$ 1.18/1.74/2.25/2.75 THEN $12 NXT 24 MTHS $$$$$$$$$$$ VERY UNDERVALUED

$200/240 THEN $300/340
MU
ARobinson ARobinson 24 minutes ago
Thanks this makes sense. Re the consulting fees, I actually wonder if GS didn't pay himself at all this way, because it would have gone from the $2m settlement to GS to FORW to SRNW back to GS, so it's circular. Anyway, that's a smaller point.

The other issue I foresee with extending
FORW SRNW
HoldEm777 HoldEm777 27 minutes ago
Murph is only trying to keep this koolaid stirred long enough for the company to dump. He can’t even admit they have lied multiple times already. Bid starting building a little today and they sold every share they could once again. This trash deserves to be delisted completely…..
NWPN
LOB LOB 30 minutes ago
The cost of a potentially already producing gold mine?
HIRU
J2003 J2003 31 minutes ago
Huge run is on deck here! No Reverse split and good financials!
AIAD

Your Recent History

NASDAQ
XGN
Exagen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved